Want to see HLYK full AI Analyst Report?
HealthLynked (HLYK) AI Stock Analysis
HealthLynked
(Other OTC:HLYK)
The overall score is low primarily because the company’s financial profile is highly stressed, with shrinking revenues, large recurring losses, negative equity, and sustained negative cash flow. Secondary pressure comes from a weak technical setup, with the share price trading below all major moving averages and momentum indicators pointing to a soft, mildly bearish trend. Valuation does not offset these risks, as the stock trades with a negative P/E and no dividend, offering limited compensation for the high financial and execution risk.
HealthLynked (HLYK) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $5.73M
- Dividend Yield
- ―
- Average Volume (3M)
- 1,074
- Price to Earnings (P/E)
- -1.4
- Beta (1Y)
- 0.48
- Revenue Growth
- -46.73%
- EPS Growth
- 21.91%
- Country
- US
- Employees
- 10
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
HealthLynked Business Overview & Revenue Model
Company Description
HealthLynked Corporation operates a digital platform in the United States for the management and archiving of patient information, utilizing cloud technology. The company's business activities are organized into four main segments: Health Services, D...
HealthLynked Financial Statement Overview
Summary
Score is very low due to sharply contracting revenue, persistent operating losses, negative equity, and ongoing cash burn, partially offset by high gross margins and some past improvement in cash outflows.
Income Statement
19Very NegativeBalance Sheet
7Very NegativeCash Flow
17Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.37M | 2.07M | 3.01M | 5.72M | 5.86M | 9.20M |
| Gross Profit | 1.34M | 2.01M | 2.91M | 2.35M | 5.40M | 6.18M |
| EBITDA | -3.19M | -2.13M | -4.36M | -2.75M | -7.05M | -9.85M |
| Net Income | -3.97M | -3.28M | -6.13M | -1.01M | -8.82M | -10.41M |
Balance Sheet | ||||||
| Total Assets | 1.59M | 1.70M | 2.22M | 4.28M | 4.58M | 10.69M |
| Cash, Cash Equivalents and Short-Term Investments | 12.84K | 37.14K | 76.24K | 247.22K | 61.89K | 3.29M |
| Total Debt | 8.08M | 5.83M | 997.85K | 1.97M | 1.28M | 978.19K |
| Total Liabilities | 9.35M | 7.46M | 5.35M | 3.48M | 4.27M | 3.49M |
| Stockholders Equity | -7.75M | -5.76M | -3.13M | 804.73K | 314.45K | 7.20M |
Cash Flow | ||||||
| Free Cash Flow | -2.30M | -1.71M | -3.50M | -4.15M | -4.39M | -3.79M |
| Operating Cash Flow | -2.30M | -1.71M | -3.49M | -4.14M | -4.36M | -3.77M |
| Investing Cash Flow | 125.00K | 125.00K | 422.40K | 3.51M | -544.75K | -341.36K |
| Financing Cash Flow | 1.30M | 1.55M | 2.90M | 824.09K | 1.68M | 7.24M |
HealthLynked Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLYK, the sentiment is Negative. The current price of 1.92 is below the 20-day moving average (MA) of 2.09, below the 50-day MA of 2.24, and below the 200-day MA of 2.99, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 34.66 is Neutral, neither overbought nor oversold. The STOCH value of 7.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HLYK.
HealthLynked Risk Analysis
HealthLynked disclosed 36 risk factors in its most recent earnings report. HealthLynked reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksHealthLynked Peers Comparison
Overall Rating
NUTX81Outperform
PIII48Neutral
DCGO43Neutral
MNDR43Neutral- HLYK40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| NUTX | 81Outperform | $1.37B | 7.63 | 51.88% | ― | 6.88% | 155.98% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| PIII | 48Neutral | $29.68M | -0.12 | 160.54% | ― | 2.81% | 26.63% |
| DCGO | 43Neutral | $24.44M | -0.13 | -115.58% | ― | -32.40% | -969.05% |
| MNDR | 43Neutral | $1.17M | -0.04 | -35.24% | ― | 4.47% | 92.03% |
| HLYK | 40Underperform | $5.71M | -1.41 | 61.14% | ― | -46.73% | 21.91% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HLYK | Healthlynked Corp | 1.94 | 0.55 | 39.21% | |
| NUTX | Clinigence Holdings Inc | 200.15 | 68.44 | 51.96% | |
| DCGO | DocGo, Inc. | 0.25 | -0.78 | -76.12% | |
| PIII | P3 Health Partners Inc. | 4.03 | -4.82 | -54.46% | |
| MNDR | Mobile-health Network Solutions Class A | 0.98 | -13.18 | -93.10% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 21, 2026